A Randomized, Double-Blind, Multicenter, Controlled Clinical Trial of Cyclosporine Plus Chloroquine vs. Cyclosporine Plus Placebo in Early-Onset Rheumatoid Arthritis

Archives of Medical Research

Volumn 35, Issue 1, 2004, Pages 36-42

  Miranda, Juan M ^a   Alvarez Nemegyei, José ^b   Saavedra, Miguel A ^a   Terán, Leobardo ^c   Galván Villegas, Federico ^c   García Figueroa, José ^c   Jara, Luis J ^a   Barile, Leonor ^c  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b Centro Médico El Fénix   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Chloroquine; Combined therapy; Cyclosporine; Early onset rheumatoid arthritis

Indexed keywords

CHLOROQUINE; CYCLOSPORIN; PLACEBO; PREDNISONE;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; DRUG SAFETY; EVALUATION; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GENERAL CONDITION IMPROVEMENT; GINGIVA HYPERPLASIA; GINGIVITIS; HEADACHE; HUMAN; HYPERTENSION; HYPERTRICHOSIS; HYPERURICEMIA; INTERMETHOD COMPARISON; JOINT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; MOUTH ULCER; NAUSEA; PAIN ASSESSMENT; PARESTHESIA; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; TREMOR; VISUAL IMPAIRMENT;

EID: 1342345296     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2003.07.008     Document Type: Article

References (35)

1. Masi A.T., Feigenbaum S.L., Kaplan S.B. Articular pattern in the early course of rheumatoid arthritis. Am J Med. 75:1983;16-26.
2. Pincus T., Callahan L.F. Taking mortality in rheumatoid arthritis seriously. Predictive markers, socioeconomic status and co-morbidity (editorial). J Rheumatol. 13:1986;841-845.
3. van der Heijde D.M., van Leeuwen M.A., van Riel P.C.L.M. Biannual radiographic assessment of hands and feet in a three year prospective follow-up of patients with early rheumatoid arthritis. Arthritis Rheumat. 35:1992;26-34.
4. Pincus T., Wolfe F. Treatment of rheumatoid arthritis: challenge to traditional paradigms. Ann Intern Med. 115:1991;825-827.
5. Felson D.T., Anderson J.J., Meenan R.F. Use of short-term efficacy/toxicity tradeoffs to select second line drugs in rheumatoid arthritis. A meta-analysis of published clinical trials. Arthritis Rheum. 35:1992;1117-1125.
6. Harris E.D. The rationale for combination therapy of rheumatoid arthritis based on pathophysiology. J Rheumatol. 23:(Suppl):1996;2-4. 44.
7. Wilske K.R., Yocum D.E. Rheumatoid arthritis: the status of combination therapy. J Rheumatol. 23:(Suppl):1996;1. 44.
8. Csuka M., Carrera G.F., Melarty D.J. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine and hydroxychloroquine: a follow-up study. JAMA. 255:1986;2385-2396.
9. Furst D.E. Clinical pharmacology of combination DMARDs therapy in rheumatoid arthritis. J Rheumatol. 23:(Suppl l):1996;86-90. 44.
10. O'Dell J., Haire C., Erikson N., Drimaski W., Palmer W., Eckhoff J., Garwood V., Maloley P., Klassen L.W., Wess S., Klein H., Moore G.F. Triple DMARD therapy of rheumatoid arthritis: efficacy. Arthritis Rheum. (Suppl):1994;S295. 37.
11. Bensen W., Tugwell P., Roberts R., Ludwin D., Ross H., Grace E., Gant M. Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies). J Rheumatol. 21:1994;2034-2038.
12. Stein C., Pincus T., Yocum D. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks. Arthritis Rheum. 40:1997;1843-1851.
13. Proudman S.M., Conaghan P.G., Richardson C., Griffiths B., Green M.J., McGonagle D., Wakefield R.J., Reece R.J., Miles S., Abedajo A., Gough A., Heliwell P., Martin M., Huston G., Pease C., Veale D.J., Isaacs J., Van der Heyde D.M., Emery P. Treatment of poor-prognosis early rheumatoid arthritis: a randomized study of treatment with methotrexate, cyclosporine A and intraarticular corticosteroids compared with sulfazalazine alone. Arthritis Rheum. 43:2000;1809-1819.
14. Salaffi F., Carotti M., Cervini C. Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis. Scand J Rheumatol. 25:1996;16-23.
15. Panayi G.S., Lanchdury J.S., Kingsdaley G.H. The important of the T cell initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum. 35:1992;729-735.
16. van Roon J.A.G., Lafeber F.P., Bijlsma J.W.G. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum. 44:2001;3-12.
17. Diijkmans B.A., de Vries E., de Vreede T.M. Synergistic and additive effect of disease modifying antirheumatic drugs combined with chloroquine on the mitogen-driven stimulation of mononuclear cells. Clin Exp Rheumatol. 8:1990;455-459.
18. Landewe R.B., Miltenburg A.M., Breedveld F.C., Daha M.R., Diijkmans B.A. Cyclosporine and chloroquine synergistically inhibit the interferon-γ production by CD4+ and CD8+ synovial T cells clone derived from a patient with rheumatoid arthritis. J Rheumatol. 19:1992;1353-1357.
19. Landewe R.B., Miltenburg A.M., Verdonk M.J. Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness. Clin Exp Immunol. 102:1995;144-151.
20. van der Borne Ben E.E.M., Landewe R.B.M., Goei The H.S., Rietveld J.H., Zwinderman A.H., Bruyn G.A., Breedveld F.G., Dijkmans B.A. Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine. J Rheumatol. 25:1998;1493-1498.
21. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324.
22. Felson D.T., Anderson J.J., Boers M. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 38:1995;727-735.
23. Cardiel M.H., Abello-Banfi M., Ruiz-Mercado R., Alarcón-Segovia D. How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI). Clin Exp Rheumatol. 11:1993;117-121.
24. Pincus T., Stein C. ACR-20: clinical or statistical significance? Arthritis Rheum. 42:1999;1572-1576.
25. Smolen J.S., Ferdinand C. Validity and reliability of the 28 count for assessment of rheumatoid arthritis. Arthritis Rheum. 38:1995;38-43.
26. Dougados M., Amor B. Cyclosporin A in rheumatoid arthritis: preliminary clinical results of an open trial. Arthritis Rheum. 30:1987;83-86.
27. Tugwell P., Bombardier C., Gent M., Bennet K.J., Benson W.G., Carete S., Chalmers A., Esdaile J.M., Klinkhoff A.V., Kraag G. Low dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet. 355:1990;1051-1055.
28. Forre O., the Norwegian Arthritis Study Group. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine: results of a 48-week multicenter study comparing low dose cyclosporine with placebo. Arthritis Rheum. 37:1994;1506-1512.
29. Pasero G., Priolo F., Marubini E. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum. 39:1996;1006-1015.
30. Altman R.D., Schiff M., Kopp E.J., The Cylosporin A Study Group. Cyclosporin A in rheumatoid arthritis: randomized placebo controlled dose finding study. J Rheumatol. 26:1999;210-2109.
31. Tugwell P., Pincus T., Yocum D., Stein M., Gluck K.O., Krang G., McKendy R., Tesser J., Broker P., Wells G. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med. 333:1995;137-141.
32. Rojkovich B., Hodinka L., Boulint G., Szegedi G., Varju T., Tomasi L., Molmar E., Szilagzi M., Szocsik K. Cyclosporin and sulfazalazine combination in the treatment of early rheumatoid arthritis. Scand J Rheumatol. 28:1999;216-221.
33. Ost L., Klintmalm G., Rigden O. Mutual interactions between prednisolone and cyclosporine in renal transplant patients. Transpl Proc. 17:1985;1252-1255.
34. Kim W.U., Seo Y.I., Park S.H., Lee W.K., Lee S.K., Poek S.I., Chro C.S., Song H.H., Kim H.Y. Treatment with cyclosporine switching to hydroxychloroquine in patients with rheumatoid arthritis. Ann Rheum Dis. 60:2001;514-517.
35. O'Dell J.R. Treating rheumatoid arthritis early: window of opportunity? Arthritis Rheum. 2:2002;283-285.